Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 168

1.

Spot urine protein-to-creatinine ratio as a diagnostic test in pre-eclampsia: A gold standard?

Berthet A, Bartolo S, Subtil D, Clouqueur E, Garabedian C, Azaïs H.

Int J Gynaecol Obstet. 2019 Dec 23. doi: 10.1002/ijgo.13094. [Epub ahead of print]

PMID:
31869445
2.

Impact of neoadjuvant chemotherapy cycles on survival of patients with advanced ovarian cancer: A French national multicenter study (FRANCOGYN).

Lecointre L, Velten M, Lodi M, Saadeh R, Lavoué V, Ouldamer L, Bendifallah S, Koskas M, Bolze PA, Collinet P, Canlorbe G, Touboul C, Huchon C, Coutant C, Faller E, Boisramé T, Gantzer J, Martin D, Baldauf JJ, Akladios C, Ballester M.

Eur J Obstet Gynecol Reprod Biol. 2019 Dec 6;245:64-72. doi: 10.1016/j.ejogrb.2019.12.001. [Epub ahead of print]

PMID:
31864157
3.

When Graves' disease resists to surgery: A rare case of an association with follicular thyroid cancer in struma ovarii.

Richa C, Quilhot P, Uzan C, Buffet C, Lussey-Lepoutre C.

Ann Endocrinol (Paris). 2019 Nov;80(5-6):329-331. doi: 10.1016/j.ando.2019.09.002. Epub 2019 Oct 18. No abstract available.

PMID:
31708080
4.

Perceptions, Relationship, and Management of Morbidly Obese Patients and the Role of Robotic Surgery.

Azaïs H, Moawad G, Uzan C, Canlorbe G, Belghiti J.

Obes Surg. 2019 Dec;29(12):4062-4063. doi: 10.1007/s11695-019-04224-5. No abstract available.

PMID:
31620976
5.

[Are there still indications of lymph node dissection in epithelial ovarian cancers after the LION trial?]

Azaïs H, Canlorbe G, Nikpayam M, Gonthier C, Belghiti J, Uzan C.

Bull Cancer. 2019 Oct 3. pii: S0007-4551(19)30342-X. doi: 10.1016/j.bulcan.2019.06.012. [Epub ahead of print] Review. French.

PMID:
31587803
6.

Cervical cancer recurrence: Proposal for a classification based on anatomical dissemination pathways and prognosis.

Bendifallah S, de Foucher T, Bricou A, Ouldamer L, Lavoue V, Varinot J, Canlorbe G, Carcopino X, Raimond E, Huguet F, Graesslin O, Touboul C, Collinet P, Huchon C, Daraï E, Ballester M; Groupe de Recherche FRANCOGYN, FRANCE.

Surg Oncol. 2019 Sep;30:40-46. doi: 10.1016/j.suronc.2019.05.004. Epub 2019 May 23.

PMID:
31500783
7.

[Should the results of the LACC trial modify French practices for the choice of surgical approach for the treatment of early-stage cervical cancer ? The point of view of the CNGOF Cancer Commission].

Canlorbe G, Levêque J, Koskas M.

Bull Cancer. 2019 Oct;106(10):843-846. doi: 10.1016/j.bulcan.2019.05.006. Epub 2019 Aug 21. French. No abstract available.

PMID:
31445672
8.

The Use of microRNAs in the Management of Endometrial Cancer: A Meta-Analysis.

Delangle R, De Foucher T, Larsen AK, Sabbah M, Azaïs H, Bendifallah S, Daraï E, Ballester M, Mehats C, Uzan C, Canlorbe G.

Cancers (Basel). 2019 Jun 16;11(6). pii: E832. doi: 10.3390/cancers11060832. Review.

9.

Impact of vaginal brachytherapy in intermediate and high-intermediate risk endometrial cancer: a multicenter study from the FRANCOGYN group.

Reboux PA, Azaïs H, Canova CH, Bendifallah S, Ouldamer L, Raimond E, Hudry D, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Daraï E, Ballester M, Lévêque J, Lavoué V, Koskas M, Uzan C, Canlorbe G.

J Gynecol Oncol. 2019 Jul;30(4):e53. doi: 10.3802/jgo.2019.30.e53. Epub 2019 Feb 7.

10.

Saved by the evidence: Hyperthermic intraperitoneal chemotherapy still has a role to play in ovarian cancer.

Lavoué V, Bakrin N, Bolze PA, Bendifallah S, Collinet P, Graesslin O, Ballester M, Akladios C, Carcopino X, Bricou A, Koskas M, Canlorbe G, Coutant C, Ouldamer L, Daraï E, Touboul C, Huchon C; Groupe de Recherche FRANCOGYN.

Eur J Surg Oncol. 2019 Oct;45(10):1757-1759. doi: 10.1016/j.ejso.2019.03.037. Epub 2019 Mar 29. No abstract available.

PMID:
30954353
11.

Characteristics of patients with cervical cancer during pregnancy: a multicenter matched cohort study. An initiative from the International Network on Cancer, Infertility and Pregnancy.

Halaska MJ, Uzan C, Han SN, Fruscio R, Dahl Steffensen K, Van Calster B, Stankusova H, Delle Marchette M, Mephon A, Rouzier R, Witteveen PO, Vergani P, Van Calsteren K, Rob L, Amant F.

Int J Gynecol Cancer. 2019 Mar 20. pii: ijgc-2018-000103. doi: 10.1136/ijgc-2018-000103. [Epub ahead of print]

PMID:
30898935
12.

Absence of predictable long-term molecular effect of ulipristal acetate (UPA) on the endometrium.

Kolanska K, Varinot J, Canlorbe G, Bergeron C, Mekinian A, Capmas P, Koskas M, Daraï E, Aractingi S, Bendifallah S, Chabbert-Buffet N.

Reprod Biomed Online. 2019 May;38(5):825-834. doi: 10.1016/j.rbmo.2018.12.013. Epub 2018 Dec 21.

13.

[Update regarding the management of vulvar cancer: The guidelines of the Assistance Publique-Hôpitaux de Paris].

Azaïs H, Pauphilet V, Belghiti J, Nikpayam M, Gonthier C, Maingon P, Conforti R, Uzan C, Canlorbe G; Groupe transversal sein-gynécologie AP–HP.

Bull Cancer. 2019 Apr;106(4):371-378. doi: 10.1016/j.bulcan.2019.01.017. Epub 2019 Mar 18. Review. French.

PMID:
30898319
14.

[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].

Lavoue V, Huchon C, Akladios C, Alfonsi P, Bakrin N, Ballester M, Bendifallah S, Bolze PA, Bonnet F, Bourgin C, Chabbert-Buffet N, Collinet P, Courbiere B, De la Motte Rouge T, Devouassoux-Shisheboran M, Falandry C, Ferron G, Fournier L, Gladieff L, Golfier F, Gouy S, Guyon F, Lambaudie E, Leary A, Lecuru F, Lefrere-Belda MA, Leblanc E, Lemoine A, Narducci F, Ouldamer L, Pautier P, Planchamp F, Pouget N, Ray-Coquard I, Rousset-Jablonski C, Senechal-Davin C, Touboul C, Thomassin-Naggara I, Uzan C, You B, Daraï E.

Bull Cancer. 2019 Apr;106(4):354-370. doi: 10.1016/j.bulcan.2019.01.014. Epub 2019 Mar 6. Review. French.

PMID:
30850152
15.

Lymphadenectomy in elderly patients with high-intermediate-risk, high-risk or advanced endometrial cancer: Time to move from personalized cancer medicine to personalized patient medicine!

Racin A, Raimond E, Bendifallah S, Nyangoh Timoh K, Ouldamer L, Canlorbe G, Hudry N, Coutant C, Graesslin O, Touboul C, Collinet P, Bricou A, Huchon C, Koskas M, Ballester M, Daraï E, Levêque J, Lavoue V; groupe de recherche FRANCOGYN.

Eur J Surg Oncol. 2019 Aug;45(8):1388-1395. doi: 10.1016/j.ejso.2019.02.015. Epub 2019 Feb 18.

16.

[Hyperthermic intra-peritoneal chemotherapy (HIPEC) saved by evidence-based medecine: Ovarian carcinomatosis, HIPEC's favorite target?]

Lavoué V, Bendifallah S, Collinet P, Graesslin O, Ballester M, Akladios C, Carcopino X, Bricou A, Koskas M, Canlorbe G, Coutant C, Bolze PA, Ouldamer L, Daraï E, Touboul C, Huchon C; Groupe de Recherche FRANCOGYN.

Bull Cancer. 2019 Mar;106(3):175-178. doi: 10.1016/j.bulcan.2018.12.009. Epub 2019 Feb 11. French. No abstract available.

PMID:
30765098
17.

Does lymphadenectomy improve survival in patients with intermediate risk endometrial cancer? A multicentric study from the FRANCOGYN Research Group.

Bougherara L, Azaïs H, Béhal H, Canlorbe G, Ballester M, Bendifallah S, Coutant C, Lavoue V, Ouldamer L, Graesslin O, Touboul C, Estevez JP, Collinet P.

Int J Gynecol Cancer. 2019 Feb;29(2):282-289. doi: 10.1136/ijgc-2018-000051. Epub 2018 Dec 21.

PMID:
30718310
18.

Laparoscopic ovarian tissue harvesting and orthotopic ovarian cortex grafting for fertility preservation: less is more.

Fortin A, Azaïs H, Uzan C, Lefebvre G, Canlorbe G, Poirot C.

Fertil Steril. 2019 Feb;111(2):408-410. doi: 10.1016/j.fertnstert.2018.11.022.

PMID:
30691635
19.

Patterns of recurrence and prognosis in locally advanced FIGO stage IB2 to IIB cervical cancer: Retrospective multicentre study from the FRANCOGYN group.

de Foucher T, Bendifallah S, Ouldamer L, Bricou A, Lavoue V, Varinot J, Canlorbe G, Carcopino X, Raimond E, Monnier L, Graesslin O, Touboul C, Collinet P, Neveu ME, Huchon C, Daraï E, Ballester M; Groupe de Recherche Francogyn, France.

Eur J Surg Oncol. 2019 Apr;45(4):659-665. doi: 10.1016/j.ejso.2018.11.014. Epub 2018 Dec 30.

PMID:
30685326
20.

How to perform a laparoscopic pelvic sentinel lymph node dissection using near-infrared fluorescence with indocyanine green in gynecological cancers.

Vésale E, Azaïs H, Belghiti J, Nikpayam M, Uzan C, Canlorbe G.

Int J Gynecol Cancer. 2019 Jan 18. pii: ijgc-2018-000074. doi: 10.1136/ijgc-2018-000074. [Epub ahead of print]

PMID:
30659031

Supplemental Content

Loading ...
Support Center